Trials / Completed
CompletedNCT01735214
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 358 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, observational study of changing from any IOP-lowering treatment to a prostaglandin analogue-containing IOP-lowering medication for patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). The decision to change medications lies with the physician according to their standard practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prostaglandin Analogue -Containing IOP-Lowering Therapy | Patients with POAG or OHT on current IOP-lowering therapy who are prescribed a prostaglandin analogue -containing IOP-lowering therapy by the physician. The decision to prescribe a change in IOP-lowering therapy lies with the physician according to their standard practice. |
Timeline
- Start date
- 2013-03-07
- Primary completion
- 2014-04-10
- Completion
- 2014-04-10
- First posted
- 2012-11-28
- Last updated
- 2019-04-18
- Results posted
- 2015-04-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01735214. Inclusion in this directory is not an endorsement.